Thomas B. Cueni




Mr. Thomas B. Cueni

Secretary General, Interpharma (Switzerland)



Chairman. Panel III. Value-added health technology assessment for health policy.

10:00-12:40, 30th November, 2012




Thomas B. Cueni is Secretary General of Interpharma, the association of the Swiss pharmaceutical research companies. Mr. Cueni is a member of the Board of the European Federation of the Pharmaceutical Industries' Associations (EFPIA) where he also chairs the Economic and Social Policy Committee. He represents the Swiss pharmaceutical research companies on various committees of the International Federation of Pharmaceutical Manufacturers Associations (IFPMA). Mr. Cueni also serves on the Swiss Federal Medicines Committee, an Advisory Body of the Swiss Government.


Mr. Cueni has a broad ranging experience in communication and public policy. This includes the successful co-ordination of referenda campaigns in Switzerland on issues such as biotechnology, pharmaceutical pricing, and animal testing. On an international level, he initiated and co-ordinated a global study by National Economic Research Associates (n/e/r/a) on ‘Financing Health Care’ which was sponsored by 35 global pharmaceutical research companies.


Prior to his appointment with Interpharma, Mr. Cueni had a career as a journalist for two Swiss newspapers. Having specialised in economic and political journalism in Switzerland, he spent four years as a London correspondent with a coverage ranging from Lawn Tennis at Wimbledon to the changing party political landscape of the early eighties, and theatre. In 1983, Mr. Cueni joined the Swiss Foreign Service as a career diplomat with postings in Vienna at the Swiss Mission to the United Nations, the International Atomic Energy Agency, and the United Nations Industrial Development Organisation, and in Paris where he was a member of the Swiss Delegation to the OECD.


Mr. Cueni studied at the Universities of Basle, London, and the Geneva Graduate Institute for International Studies, and has a degree in economics (University of Basle) and a post-graduate degree in politics (M.Sc.) from the London School of Economics.